| Year |
Citation |
Score |
| 2024 |
Ren J, Liao X, Lewis JM, Chang J, Qu R, Carlson KR, Foss F, Girardi M. Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nature Communications. 15: 519. PMID 38225288 DOI: 10.1038/s41467-024-44786-2 |
0.336 |
|
| 2023 |
Avery J, Kim SR, Cheng W, Foss F, Girardi M. FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes. Jid Innovations : Skin Science From Molecules to Population Health. 3: 100212. PMID 37674691 DOI: 10.1016/j.xjidi.2023.100212 |
0.314 |
|
| 2023 |
Yu B, Kim SR, Roy SF, Girardi M. A rare presentation of cutaneous T-cell lymphoma mimicking morphea. Jaad Case Reports. 33: 59-61. PMID 36860808 DOI: 10.1016/j.jdcr.2023.01.007 |
0.335 |
|
| 2022 |
Ren J, Qu R, Rahman NT, Lewis JM, King ALO, Liao X, Mirza FN, Carlson KR, Huang Y, Gigante S, Evans B, Rajendran BK, Xu S, Wang G, Foss FM, ... ... Girardi M, et al. Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations. Blood Advances. PMID 35947128 DOI: 10.1182/bloodadvances.2022008168 |
0.344 |
|
| 2021 |
Dehner CA, Ruff WE, Greiling T, Pereira MS, Redanz S, McNiff J, Girardi M, Kriegel MA. Malignant T Cell Activation by a Species Isolated from Cutaneous T-Cell Lymphoma Lesions. Jid Innovations : Skin Science From Molecules to Population Health. 2: 100084. PMID 35199089 DOI: 10.1016/j.xjidi.2021.100084 |
0.343 |
|
| 2021 |
King ALO, Mirza FN, Lewis JM, Carlson KR, Huntington S, Foss FM, Girardi M. B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma. Jaad Case Reports. 8: 89-92. PMID 33537387 DOI: 10.1016/j.jdcr.2020.12.025 |
0.318 |
|
| 2020 |
Mirza FN, Yumeen S, Girardi M. Disparities in Outcomes of CD8+ Cutaneous T Cell Lymphoma by Race and Presenting Lesion Location British Journal of Dermatology. 184: 170-171. PMID 32730673 DOI: 10.1111/Bjd.19426 |
0.355 |
|
| 2020 |
Isufi I, Seropian S, Gowda L, Wilson LD, Roberts K, Girardi M, Perreault S, Foss F. Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas. Leukemia & Lymphoma. 1-7. PMID 32643494 DOI: 10.1080/10428194.2020.1790555 |
0.381 |
|
| 2020 |
Yumeen S, Mirza FN, Lewis JM, King ALO, Kim SR, Carlson KR, Umlauf SR, Surovtseva YV, Foss FM, Girardi M. JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL. Blood Advances. 4: 2213-2226. PMID 32437546 DOI: 10.1182/Bloodadvances.2020001756 |
0.391 |
|
| 2020 |
Yumeen S, Girardi M. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma. The Yale Journal of Biology and Medicine. 93: 111-121. PMID 32226341 |
0.361 |
|
| 2020 |
Mirza F, Yumeen S, Lewis J, King A, Kim S, Carlson K, Foss F, Girardi M. 110 RNA expression analysis in stage IVA-B cutaneous T-cell lymphoma to identify novel biomarkers of prognosis and diagnosis Journal of Investigative Dermatology. 140: S13. DOI: 10.1016/J.Jid.2020.03.113 |
0.354 |
|
| 2019 |
Cheraghlou S, Agogo GO, Girardi M. The impact of facility characteristics on Merkel cell carcinoma outcomes: a retrospective cohort study Journal of the American Academy of Dermatology. PMID 31473294 DOI: 10.1016/J.Jaad.2019.08.058 |
0.321 |
|
| 2019 |
Ventura A, Vassall A, Yurter A, Robinson E, Filler R, Hanlon D, Meeth K, Ezaldein H, Girardi M, Sobolev O, Bosenberg MW, Edelson RL. Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells. Journal of Visualized Experiments : Jove. PMID 31157760 DOI: 10.3791/59370 |
0.366 |
|
| 2019 |
Foss FM, Parker TL, Girardi M, Li A. Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate. Leukemia & Lymphoma. 1-4. PMID 31119966 DOI: 10.1080/10428194.2019.1612061 |
0.442 |
|
| 2019 |
Yumeen S, King A, Kim S, Lewis J, Carlson K, Umlauf S, Surovtseva Y, Foss F, Girardi M. 676 Exploring novel therapeutic targets in the treatment of cutaneous T-cell lymphoma Journal of Investigative Dermatology. 139: S116. DOI: 10.1016/J.Jid.2019.03.752 |
0.412 |
|
| 2018 |
Foss FM, Parker TL, Girardi M, Li A. Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate. Clinical Lymphoma, Myeloma & Leukemia. PMID 30181105 DOI: 10.1016/J.Clml.2018.06.020 |
0.408 |
|
| 2018 |
Kim SR, Lewis JM, Cyrenne BM, Monico PF, Mirza FN, Carlson KR, Foss FM, Girardi M. BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition. Oncotarget. 9: 29193-29207. PMID 30018745 DOI: 10.18632/Oncotarget.25670 |
0.398 |
|
| 2018 |
Chang LW, Patrone CC, Yang W, Rabionet R, Gallardo F, Espinet B, Sharma MK, Girardi M, Tensen CP, Vermeer M, Geskin LJ. An integrated data resource for genomic analysis of cutaneous T-cell lymphoma. The Journal of Investigative Dermatology. PMID 29981755 DOI: 10.1016/J.Jid.2018.06.176 |
0.358 |
|
| 2018 |
Ventura A, Vassall A, Robinson E, Filler R, Hanlon D, Meeth K, Ezaldein H, Girardi M, Sobolev O, Bosenberg MW, Edelson RL. Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anti-Cancer Immunity. Cancer Research. PMID 29764863 DOI: 10.1158/0008-5472.Can-18-0171 |
0.392 |
|
| 2018 |
Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells. . 2001. 294: 605-609. Journal of Immunology (Baltimore, Md. : 1950). 200: 3031-3035. PMID 29685949 |
0.312 |
|
| 2018 |
Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M, Ruiz DZ, Renfroe SC, Vieira SM, Ruff WE, Sim S, Kriegel C, Glanternik J, Chen X, Girardi M, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Science Translational Medicine. 10. PMID 29593104 DOI: 10.1126/Scitranslmed.Aan2306 |
0.35 |
|
| 2018 |
Cyrenne BM, Gibson JF, Subtil A, Girardi M, Isufi I, Seropian S, Foss F. Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia. 18: e85-e93. PMID 29223388 DOI: 10.1016/J.Clml.2017.11.004 |
0.409 |
|
| 2018 |
Dehner C, Ruff W, Foss F, Girardi M, Kriegel M. LB1550 Skin commensals as instigators of cutaneous T cell lymphoma Journal of Investigative Dermatology. 138: B14. DOI: 10.1016/J.Jid.2018.06.086 |
0.431 |
|
| 2017 |
Cyrenne BM, Subtil A, Girardi M, Foss F. Primary cutaneous aggressive epidermotropic cytotoxic CD8(+) T-cell lymphoma: long-term remission after brentuximab vedotin. International Journal of Dermatology. PMID 29047111 DOI: 10.1111/Ijd.13792 |
0.375 |
|
| 2017 |
Cyrenne BM, Lewis J, Weed J, Carlson K, Mirza FN, Foss F, Girardi M. Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients. Blood. PMID 28972015 DOI: 10.1182/Blood-2017-06-792150 |
0.41 |
|
| 2017 |
Foss FM, Girardi M. Mycosis Fungoides and Sezary Syndrome. Hematology/Oncology Clinics of North America. 31: 297-315. PMID 28340880 DOI: 10.1016/J.Hoc.2016.11.008 |
0.385 |
|
| 2017 |
Guitart J, Martinez-Escala ME, Subtil A, Duvic M, Pulitzer MP, Olsen EA, Kim E, Rook AH, Samimi SS, Wood GS, Girardi M, Junkins-Hopkins J, Ivan DS, Selim MA, Sable KA, et al. Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28128277 DOI: 10.1038/Modpathol.2016.240 |
0.453 |
|
| 2017 |
Cyrenne B, Lewis J, Weed J, Mirza F, Carlson K, Girardi M. 694 Combination Bcl-2 and HDAC inhibition in the treatment of cutaneous T-cell lymphoma Journal of Investigative Dermatology. 137. DOI: 10.1016/J.Jid.2017.02.717 |
0.423 |
|
| 2016 |
Shi VJ, Rodic N, Gettinger S, Leventhal JS, Neckman JP, Girardi M, Bosenberg M, Choi JN. Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy. Jama Dermatology. PMID 27411054 DOI: 10.1001/Jamadermatol.2016.2226 |
0.302 |
|
| 2016 |
Kibbi N, Sobolev O, Girardi M, Edelson RL. Induction of anti-tumor CD8 T cell responses by experimental ECP-induced human dendritic antigen presenting cells Transfusion and Apheresis Science. 55: 146-152. PMID 27317354 DOI: 10.1016/J.Transci.2016.06.001 |
0.407 |
|
| 2016 |
Neckman JP, Kim J, Mathur M, Myung P, Girardi M. Diverse cutaneous manifestations of Erdheim-Chester disease in a woman with a history of Langerhans cell histiocytosis. Jaad Case Reports. 2: 128-31. PMID 27051852 DOI: 10.1016/J.Jdcr.2015.10.010 |
0.341 |
|
| 2016 |
Gibson JF, Huang J, Liu KJ, Carlson KR, Foss F, Choi J, Edelson R, Hussong JW, Mohl R, Hill S, Girardi M. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction. Journal of the American Academy of Dermatology. PMID 26874819 DOI: 10.1016/J.Jaad.2015.12.018 |
0.433 |
|
| 2016 |
Greiling T, Dehner C, Renfroe S, Chen X, Vieira S, Ruff W, Girardi M, Goodman A, Wolin S, Kriegel M. 234 Anti-Ro60 T and B cells in human lupus cross-react with Ro60 orthologs from cutaneous commensals Journal of Investigative Dermatology. 136: S42. DOI: 10.1016/J.Jid.2016.02.263 |
0.348 |
|
| 2015 |
Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, Bjornson RD, Maman Y, Wang T, Tordoff J, Carlson K, Overton JD, Liu KJ, Lewis JM, Devine L, ... ... Girardi M, et al. Genomic landscape of cutaneous T cell lymphoma. Nature Genetics. PMID 26192916 DOI: 10.1038/Ng.3356 |
0.401 |
|
| 2015 |
Lewis JM, Bürgler CD, Freudzon M, Golubets K, Gibson JF, Filler RB, Girardi M. Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis. The Journal of Investigative Dermatology. PMID 26053049 DOI: 10.1038/Jid.2015.207 |
0.37 |
|
| 2015 |
Gibson JF, Alpdogan O, Subtil A, Girardi M, Wilson LD, Roberts K, Foss F. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma. Journal of the American Academy of Dermatology. 72: 1010-5.e5. PMID 25981001 DOI: 10.1016/J.Jaad.2015.01.003 |
0.417 |
|
| 2015 |
Lewis JM, Bürgler CD, Fraser JA, Liao H, Golubets K, Kucher CL, Zhao PY, Filler RB, Tigelaar RE, Girardi M. Mechanisms of chemical cooperative carcinogenesis by epidermal langerhans cells. The Journal of Investigative Dermatology. 135: 1405-14. PMID 25233073 DOI: 10.1038/Jid.2014.411 |
0.331 |
|
| 2015 |
James E, Sokhn JG, Gibson JF, Carlson K, Subtil A, Girardi M, Wilson LD, Foss F. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature. Leukemia & Lymphoma. 56: 951-7. PMID 24996443 DOI: 10.3109/10428194.2014.938331 |
0.357 |
|
| 2015 |
Weed J, Girardi M. The difficult- and often delayed-diagnosis of CTCL Science Translational Medicine. 7. DOI: 10.1126/Scitranslmed.Aad2518 |
0.386 |
|
| 2014 |
Durazzo TS, Tigelaar RE, Filler R, Hayday A, Girardi M, Edelson RL. Induction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. 50: 370-8. PMID 24360371 DOI: 10.1016/J.Transci.2013.11.008 |
0.332 |
|
| 2014 |
Gonzalez AL, Berger CL, Remington J, Girardi M, Tigelaar RE, Edelson RL. Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy. Clinical and Experimental Immunology. 175: 449-57. PMID 24188174 DOI: 10.1111/Cei.12231 |
0.311 |
|
| 2013 |
Engberg AK, Bunick CG, Subtil A, Ko CJ, Girardi M. Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: e87-9. PMID 23182990 DOI: 10.1200/Jco.2012.42.9241 |
0.348 |
|
| 2013 |
Lewis J, Girardi M, Vakkalanka S, Viswanadha S, Bertoni F. RP6530, a Dual PI3Kδ/γ Inhibitor, Attenutates AKT Phosphorylation and Induces Apoptosis In Primary Cutaneous T Cell Lymphoma (CTCL) Cells Blood. 122: 4418-4418. DOI: 10.1182/Blood.V122.21.4418.4418 |
0.409 |
|
| 2012 |
Modi BG, Neustadter J, Binda E, Lewis J, Filler RB, Roberts SJ, Kwong BY, Reddy S, Overton JD, Galan A, Tigelaar R, Cai L, Fu P, Shlomchik M, Kaplan DH, ... ... Girardi M, et al. Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science (New York, N.Y.). 335: 104-8. PMID 22223807 DOI: 10.1126/Science.1211600 |
0.366 |
|
| 2012 |
Lin WM, Lewis JM, Filler RB, Modi BG, Carlson KR, Reddy S, Thornberg A, Saksena G, Umlauf S, Oberholzer PA, Karpova M, Getz G, Mane S, Garraway LA, Dummer R, ... ... Girardi M, et al. Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients. The Journal of Investigative Dermatology. 132: 188-97. PMID 21881587 DOI: 10.1038/Jid.2011.254 |
0.373 |
|
| 2012 |
Parker TL, Barbarotta L, Girardi M, Foss FM. Cutaneous Toxicity Associated with Pralatrexate in Cutaneous and Peripheral T-Cell Lymphoma Blood. 120: 3660-3660. DOI: 10.1182/Blood.V120.21.3660.3660 |
0.386 |
|
| 2012 |
Morcos SM, Girardi M, Subtil A, Wilson LD, Cowper SE. Mycosis fungoides exhibiting features of a dermatofibroma: A case report and review of the literature Journal of Cutaneous Pathology. 39: 40-46. DOI: 10.1111/J.1600-0560.2011.01804.X |
0.317 |
|
| 2011 |
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, ... ... Girardi M, et al. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2598-607. PMID 21576639 DOI: 10.1200/Jco.2010.32.0630 |
0.355 |
|
| 2011 |
Hansen JE, Reza F, Nallur S, Lewis J, Carlson KR, Lin WM, Weidhaas JB, Wilson LD, Girardi M. MicroRNA Profiling of Cutaneous T-cell Lymphoma Cell Lines: Implications for Pathophysiology and Therapy International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.045 |
0.402 |
|
| 2010 |
Lewis J, Filler R, Smith DA, Golubets K, Girardi M. The contribution of Langerhans cells to cutaneous malignancy. Trends in Immunology. 31: 460-6. PMID 21071271 DOI: 10.1016/J.It.2010.10.001 |
0.387 |
|
| 2010 |
Kim YH, Girardi M, Duvic M, Kuzel T, Link BK, Pinter-Brown L, Rook AH. Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 63: 975-983. PMID 20888065 DOI: 10.1016/J.Jaad.2009.12.052 |
0.402 |
|
| 2010 |
Trufant JW, Kreizenbeck GM, Carlson KR, Muthusamy V, Girardi M, Bosenberg MW. A transient epidermolysis bullosa simplex-like phenotype associated with bexarotene treatment in a G138E KRT5 heterozygote. Journal of Cutaneous Pathology. 37: 1155-60. PMID 20849457 DOI: 10.1111/J.1600-0560.2010.01557.X |
0.346 |
|
| 2010 |
Berger C, Hoffmann K, Vasquez JG, Mane S, Lewis J, Filler R, Lin A, Zhao H, Durazzo T, Baird A, Lin W, Foss F, Christensen I, Girardi M, Tigelaar R, et al. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. Blood. 116: 4838-47. PMID 20720185 DOI: 10.1182/Blood-2009-11-256040 |
0.372 |
|
| 2010 |
Lin WM, Girardi M. More or less: copy number alterations in mycosis fungoides. The Journal of Investigative Dermatology. 130: 926-8. PMID 20231832 DOI: 10.1038/Jid.2009.370 |
0.381 |
|
| 2010 |
Kwong BY, Roberts SJ, Silberzahn T, Filler RB, Neustadter JH, Galan A, Reddy S, Lin WM, Ellis PD, Langford CF, Hayday AC, Girardi M. Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. The Journal of Investigative Dermatology. 130: 1726-36. PMID 19924136 DOI: 10.1038/Jid.2009.362 |
0.413 |
|
| 2009 |
Craiglow B, Hinds G, Antaya R, Girardi M. Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole. Pediatric Dermatology. 26: 493-5. PMID 19689543 DOI: 10.1111/J.1525-1470.2009.00971.X |
0.306 |
|
| 2009 |
Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, Silva-Santos B. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nature Immunology. 10: 427-36. PMID 19270712 DOI: 10.1038/Ni.1717 |
0.404 |
|
| 2009 |
Hansen JE, Wilson LD, Carlson K, Girardi M. Addition of TSEBT to ECP Reduces Circulating Malignant Cells in Leukemic Cutaneous T-cell Lymphoma International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1097 |
0.448 |
|
| 2008 |
Boyden LM, Lewis JM, Barbee SD, Bas A, Girardi M, Hayday AC, Tigelaar RE, Lifton RP. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells. Nature Genetics. 40: 656-62. PMID 18408721 DOI: 10.1038/Ng.108 |
0.406 |
|
| 2008 |
Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nature Immunology. 9: 146-54. PMID 18176566 DOI: 10.1038/Ni1556 |
0.375 |
|
| 2008 |
Prasad S, Cody V, Hanlon D, Roberts S, Filler R, Edelson RL, Dobrucki W, Sinusas A, Girardi M, Birchall MA. Transimmunization for immunotherapy of head and neck squamous cell carcinoma (HNSCC) Clinical Otolaryngology. 33: 644-644. DOI: 10.1111/J.1749-4486.2008.01843_11.X |
0.414 |
|
| 2007 |
Filler RB, Roberts SJ, Girardi M. Cutaneous two-stage chemical carcinogenesis. Csh Protocols. 2007: pdb.prot4837. PMID 21357170 DOI: 10.1101/Pdb.Prot4837 |
0.315 |
|
| 2007 |
Girardi M. Cutaneous perspectives on adaptive immunity Clinical Reviews in Allergy and Immunology. 33: 4-14. PMID 18094943 DOI: 10.1007/S12016-007-0040-9 |
0.352 |
|
| 2007 |
Roberts SJ, Ng BY, Filler RB, Lewis J, Glusac EJ, Hayday AC, Tigelaar RE, Girardi M. Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 104: 6770-5. PMID 17412837 DOI: 10.1073/Pnas.0604982104 |
0.426 |
|
| 2006 |
Girardi M, Berger CL, Wilson LD, Christensen IR, Thompson KR, Glusac EJ, Edelson RL. Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leukemia & Lymphoma. 47: 1495-503. PMID 16966259 DOI: 10.1080/10428190600581419 |
0.428 |
|
| 2006 |
Lewis JM, Girardi M, Roberts SJ, Barbee SD, Hayday AC, Tigelaar RE. Selection of the cutaneous intraepithelial gammadelta+ T cell repertoire by a thymic stromal determinant. Nature Immunology. 7: 843-50. PMID 16829962 DOI: 10.1038/Ni1363 |
0.436 |
|
| 2006 |
Girardi M, Lewis JM, Filler RB, Hayday AC, Tigelaar RE. Environmentally responsive and reversible regulation of epidermal barrier function by gammadelta T cells. The Journal of Investigative Dermatology. 126: 808-14. PMID 16439970 DOI: 10.1038/Sj.Jid.5700120 |
0.426 |
|
| 2006 |
Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. The Journal of Investigative Dermatology. 126: 25-31. PMID 16417214 DOI: 10.1038/sj.jid.5700003 |
0.314 |
|
| 2006 |
Girardi M. Immunosurveillance and immunoregulation by γδ T cells Journal of Investigative Dermatology. 126: 25-31. DOI: 10.1038/Sj.Jid.5700003 |
0.422 |
|
| 2005 |
Girardi M, Duncan KO, Tigelaar RE, Imaeda S, Watsky KL, McNiff JM. Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis. The American Journal of Dermatopathology. 27: 343-6. PMID 16121058 DOI: 10.1097/01.Dad.0000160982.75176.6C |
0.353 |
|
| 2005 |
Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunology. 6: 928-37. PMID 16116470 DOI: 10.1038/Ni1239 |
0.363 |
|
| 2005 |
Girardi M, Hayday AC. Immunosurveillance by gammadelta T cells: focus on the murine system. Chemical Immunology and Allergy. 86: 136-50. PMID 15976492 DOI: 10.1159/000086658 |
0.427 |
|
| 2004 |
Kim Y, Girardi M, McAuley S, Schmalbach T. Cutaneous T-cell lymphoma (CTCL) responses to a TLR9 agonist CPG immunomodulator (CPG 7909), a phase I study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 6600. PMID 28016598 DOI: 10.1200/Jco.2004.22.14_Suppl.6600 |
0.392 |
|
| 2004 |
Berger CL, Mariwalla K, Girardi M, Edelson RL. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma. Advances in Dermatology. 20: 217-35. PMID 15544202 |
0.337 |
|
| 2004 |
Girardi M. Cutaneous biology of γδ T cells Advances in Dermatology. 20: 203-215. PMID 15544201 |
0.355 |
|
| 2004 |
Girardi M, Heald PW, Wilson LD. The Pathogenesis of Mycosis Fungoides New England Journal of Medicine. 350: 1978-1988. PMID 15128898 DOI: 10.1056/Nejmra032810 |
0.418 |
|
| 2004 |
Girardi M, Oppenheim D, Glusac EJ, Filler R, Balmain A, Tigelaar RE, Hayday AC. Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma. The Journal of Investigative Dermatology. 122: 699-706. PMID 15086556 DOI: 10.1111/J.0022-202X.2004.22342.X |
0.422 |
|
| 2003 |
Girardi M, Knobler R, Edelson R. Selective immmunotherapy through extracorporeal photochemotherapy: Yesterday, today, and tomorrow Hematology/Oncology Clinics of North America. 17: 1391-1403. PMID 14710891 DOI: 10.1016/S0889-8588(03)00106-0 |
0.357 |
|
| 2003 |
Girardi M, Glusac E, Filler RB, Roberts SJ, Propperova I, Lewis J, Tigelaar RE, Hayday AC. The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. The Journal of Experimental Medicine. 198: 747-55. PMID 12953094 DOI: 10.1084/Jem.20021282 |
0.453 |
|
| 2003 |
Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z. γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity Journal of Experimental Medicine. 198: 433-442. PMID 12900519 DOI: 10.1084/Jem.20030584 |
0.401 |
|
| 2003 |
Girardi M, Sherling MA, Filler RB, Shires J, Theodoridis E, Hayday AC, Tigelaar RE. Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants. Immunology. 109: 1-7. PMID 12709011 DOI: 10.1046/J.1365-2567.2003.01616.X |
0.348 |
|
| 2002 |
Girardi M, Berger C, Hanlon D, Edelson RL. Efficient tumor antigen loading of dendritic antigen presenting cells by transimmunization Technology in Cancer Research and Treatment. 1: 65-69. PMID 12614179 DOI: 10.1177/153303460200100109 |
0.404 |
|
| 2002 |
Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL. Transimmunization, a novel approach for tumor immunotherapy. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. 26: 205-16. PMID 12126207 DOI: 10.1016/S1473-0502(02)00014-9 |
0.359 |
|
| 2002 |
Girardi M, Schechner J, Glusac E, Berger C, Edelson R. Transimmunization and the evolution of extracorporeal photochemotherapy Transfusion and Apheresis Science. 26: 181-190. PMID 12126204 DOI: 10.1016/S1473-0502(02)00011-3 |
0.441 |
|
| 2002 |
Girardi M, Lewis J, Glusac E, Filler RB, Geng L, Hayday AC, Tigelaar RE. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. The Journal of Experimental Medicine. 195: 855-67. PMID 11927630 DOI: 10.1084/Jem.20012000 |
0.389 |
|
| 2001 |
Knobler R, Girardi M. Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas Annals of the New York Academy of Sciences. 941: 123-138. PMID 11594566 DOI: 10.1111/J.1749-6632.2001.Tb03716.X |
0.463 |
|
| 2001 |
Berger CL, Longley J, Hanlon D, Girardi M, Edelson R. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma. Annals of the New York Academy of Sciences. 941: 106-22. PMID 11594564 DOI: 10.1111/J.1749-6632.2001.Tb03715.X |
0.408 |
|
| 2001 |
Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by gammadelta T cells. Science (New York, N.Y.). 294: 605-9. PMID 11567106 DOI: 10.1126/Science.1063916 |
0.446 |
|
| 2000 |
Girardi M, Heald PW. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease: Two indications for photopheresis in dermatology Dermatologic Clinics. 18: 417-423. PMID 10943537 DOI: 10.1016/S0733-8635(05)70190-X |
0.399 |
|
| 1999 |
Girardi M, McNiff JM, Heald PW. Extracorporeal photochemotherapy in human and murine graft-versus-host disease Journal of Dermatological Science. 19: 106-113. PMID 10098701 DOI: 10.1016/S0923-1811(98)00066-8 |
0.429 |
|
| 1998 |
Berger C, Hanlon D, Girardi M, Dong X, Yang S, Edelson R. Immunoprotection against tumor-specific class I-associated T lymphoma antigens Journal of Dermatological Science. 16. DOI: 10.1016/S0923-1811(98)83945-5 |
0.346 |
|
| 1995 |
Girardi M, Hereid P, Tigelaar RE. Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes Journal of Investigative Dermatology. 104: 177-182. PMID 7829872 DOI: 10.1111/1523-1747.Ep12612741 |
0.318 |
|
| 1995 |
Dudley EC, Girardi M, Owen MJ, Hayday AC. α β and γ δ T cells can share a late common precursor Current Biology. 5: 659-669. PMID 7552177 DOI: 10.1016/S0960-9822(95)00131-X |
0.406 |
|
| Show low-probability matches. |